1.
Pediatr Infect Dis J
; 41(6): e259-e262, 2022 06 01.
Article
in English
| MEDLINE | ID: covidwho-1806684
ABSTRACT
Immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pediatric patients with malignant disease may be affected by tumor therapy. Here, we report the case of a child with rhabdomyosarcoma and recurrent SARS-CoV-2 infection. Immunologic responses, analyzed by T-cell activity and anti-viral IgG levels, were impaired and not durable as a result of intensive radiochemotherapy.